Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion type Assertion NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_head.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion description "[GenoMEL, comprising major familial melanoma research groups from North America, Europe, Asia, and Australia has created the largest familial melanoma sample yet available to characterize mutations in the high-risk melanoma susceptibility genes CDKN2A/alternate reading frames (ARF), which encodes p16 and p14ARF, and CDK4 and to evaluate their relationship with pancreatic cancer (PC), neural system tumors (NST), and uveal melanoma (UM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_provenance.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion evidence source_evidence_literature NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_provenance.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion SIO_000772 17047042 NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_provenance.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion wasDerivedFrom befree-20140225 NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_provenance.
- NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_assertion wasGeneratedBy ECO_0000203 NP252870.RA213ssuOiAm4vRaop5ZEmEskz6WSCiJgL-OAG4Bq-zBI130_provenance.